Christine Marie Janson

1 Patent

• US126114092026

  Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a PD-1/PD-L1 Inhibitor

  CHEMOCENTRYX, Inc.

  0 cites